Pharma Giants Sidelined in R15.5bn HIV Drug Tender

Original Article by Tamar Kahn | Business Day | 22 August 2025

The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.

The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Thembisile Xulu Named New Health Director-General

Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.

Read more...

Gauteng Nurse Shortage Deepens, Threatening NHI Rollout

Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.

Read more...

Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options

Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.

Read more...